Liver Disease Clinical Trial
Official title:
Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy
Background: In a liver biopsy, a small piece of liver is removed. A percutaneous liver biopsy
(PLB) is done through a needle on the right side of your belly. In a transjugular liver
biopsy (TLB), the right side of the neck is numbed and a straw-like tube is put in. The tube
goes down to your liver and a piece of liver is removed. Researchers want to learn more about
the pain people feel after each of these procedures.
Objectives: To compare whether there is more pain associated with the PLB versus TLB.
Eligibility: Adults 18 years or older enrolled in a separate protocol (91-DK-0214) for liver
biopsy. They must be able to read, write, and speak English.
Design: Under the separate protocol (91-DK-0214), participants will be screened and have a
liver biopsy.
Before the biopsy, participants will give their medical history. They will answer questions
about past surgeries and how they feel about pain.
Participants will have a pain test with a device called a dolorimeter. They will sit up with
their feet on the ground, and put their thumbs on a table. They will feel pressure on each
thumb until it they say it is painful.
Before the biopsy and 2, 4, and 6 hours after the biopsy, they will answer pain questions.
Millions of Americans are diagnosed with some form of Hepatitis or other liver disease
requiring treatment. Liver biopsies are frequently performed mainly to stage disease, aid in
diagnosis and to guide treatment. As part of the assessment of Hepatitis patients, a liver
biopsy is frequently part of the regimen. Liver biopsy procedures can be performed using one
of two methods: percutaneous liver biopsy (PLB) or transjugular liver biopsy (TLB). Alknawy &
Shiffman (2007) discuss approaches of percutaneous liver biopsy that included the
percussion-palpation approach, image guided, ultrasound assisted, ultrasound guided and type
of biopsy needle used. The method of liver biopsy selected will not be randomly assigned but
will be determined by the hepatologist caring for the patient. Pain can be a complication
following a liver biopsy requiring adequate pain management.
Despite an extensive review of previous studies, none were found that discussed the pain
experiences of patients who have undergone PLB versus TLB. This study proposes to compare the
amount of pain experienced by patients who have undergone PLB versus TLB. Thirty-two male and
female patients age 18 years and older who meet study criteria will be invited to
participate. The participants will be placed into either the PLB or TLB group with each group
consisting of 16 male or 16 female participants. Prior to the biopsy and within the first 6
hours post procedure, at the 2, 4 and 6-hour time points, the patient will be asked to rate
their pain on the Visual Analogue Scale (VAS) and on the Numeric Pain Scale (NPS).
Additionally, the dolorimeter will be used pre liver biopsy along with the VAS and the NPS as
standardized pain measurements.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02798861 -
Controlled Attenuation Parameter (CAP) in Liver Allografts
|
||
Completed |
NCT01968395 -
Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure
|
Phase 4 | |
Completed |
NCT01437969 -
Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.
|
||
Recruiting |
NCT00155376 -
Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography
|
Phase 4 | |
Recruiting |
NCT00172705 -
Quantitative Diagnosis of Fatty Liver by Dual Energy CT Technique
|
N/A | |
Completed |
NCT04185454 -
Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese
|
N/A | |
Completed |
NCT02506335 -
Liver Function Measured by HepQuant-SHUNT in the Prediction of Outcomes in Patients With Heart Disease
|
Early Phase 1 | |
Completed |
NCT02520609 -
Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
|
||
Completed |
NCT02306018 -
Evaluation of a New Calibrated Pulse Wave Analysis Method(EV1000™/volumeView™) for Cardiac Output Monitoring in Adult Liver Transplantation
|
N/A | |
Completed |
NCT01970904 -
Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients
|
N/A | |
Completed |
NCT01988753 -
Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases
|
||
Terminated |
NCT00741117 -
Conjugated Hyperbilirubinemia and Pulse Oximetry
|
N/A | |
Enrolling by invitation |
NCT01483248 -
Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis
|
Phase 1/Phase 2 | |
Completed |
NCT00074386 -
Kidney and Liver Transplantation in People With HIV
|
N/A | |
Completed |
NCT00245830 -
Ischemic Preconditioning of Liver in Cadaver Donors
|
N/A | |
Completed |
NCT02329821 -
Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection
|
N/A | |
Completed |
NCT01303549 -
Anidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant Recipients
|
Phase 4 | |
Completed |
NCT01650181 -
Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic Steatohepatitis
|
Phase 4 | |
Completed |
NCT00799851 -
A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices
|
Phase 4 | |
Completed |
NCT00058890 -
Gabapentin to Treat Itch in Patients With Liver Disease
|
Phase 3 |